Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition
Abstract Neprilysin (NEP) cleaves active forms of A- and B-type natriuretic peptides (ANP and BNP) at multiple sites, reducing their compensatory effects in heart failure. Therapeutic inhibition of NEP by sacubitrilat may potentiate the beneficial effects of natriuretic peptides. Neprilysin 2 (NEP2)...
Saved in:
| Main Authors: | Elizaveta M. Selezneva, Evgeniya E. Feygina, Liudmila V. Ageeva, Fedor N. Rozov, Irina V. Kopylova, Evgeny P. Altshuler, Alexander G. Semenov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-10166-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased natriuretic peptides not associated with heart failure
by: A. M. Chaulin, et al.
Published: (2021-01-01) -
Natriuretic Peptides in Chronic Heart Failure
by: Hans-Peter Brunner-La Rocca, et al.
Published: (2019-01-01) -
Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01) -
Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01) -
Natriuretic Peptides: Biochemistry, Physiology, Clinical Implication
by: I. A. Kozlova, et al.
Published: (2009-02-01)